Inventor · disambiguated record
Christopher Lawrence Carroll
Also filed as: CARROLL CHRISTOPHER · CARROLL CHRISTOPHER L · CARROLL CHRISTOPHER LAWRENCE
21 granted patents·8 pending applications·95 citations·filing 2013–2024
94Inventor score
Files withUNIV TEXAS22NAVIRE PHARMA INC3BOARD OF REGENTS UNIV OF TEXAS SYSTEM2INST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT1KYMERA THERAPEUTICS INC1
Top patents by PatentIndex Score
29 records- 0196US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0295US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0394US12186324B2Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2021·Granted Jan 7, 2025·3 cites·26 claims
- 0494US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0593US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0692US10392376B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Aug 27, 2019·7 cites·32 claims
- 0792US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 0889US11058688B2Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jul 13, 2021·3 cites·41 claims
- 0989US10421765B2Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Sep 24, 2019·7 cites·39 claims
- 1087US11104675B2PTPN11 inhibitorsNAVIRE PHARMA INC·Filed 2019·Granted Aug 31, 2021·6 cites·24 claims
- 1186US10800769B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Oct 13, 2020·2 cites·16 claims
- 1286US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1385US10899769B2Imidazopiperazinone inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·3 cites·26 claims
- 1484US10745420B2Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Aug 18, 2020·2 cites·26 claims
- 1583US9481692B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2015·Granted Nov 1, 2016·4 cites·10 claims
- 1682US10208059B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Feb 19, 2019·3 cites·6 claims
- 1780US11001594B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2018·Granted May 11, 2021·1 cites·12 claims
- 1880US9018380B2Heterocyclic modulators of HIF activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Granted Apr 28, 2015·7 cites·10 claims
- 1980US2025127792A1Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2024·Application pending·0 cites
- 2080US2025188074A1Ptpn11 inhibitorsNAVIRE PHARMA INC·Filed 2024·Application pending·0 cites
- 2176US10800774B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Oct 13, 2020·2 cites·25 claims
- 2275US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2374US11945815B2PTPN11 inhibitorsNAVIRE PHARMA INC·Filed 2021·Granted Apr 2, 2024·0 cites·16 claims
- 2474US10894052B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Jan 19, 2021·1 cites·32 claims
- 2567US11434233B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2020·Granted Sep 6, 2022·0 cites·21 claims
- 2664US2023416261A1Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2762US2025034091A1Small molecule inhibitors of lanosterol synthaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 2840US2016002204A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 2935US2016002248A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →